PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Daiki Matsubara

Hiroshima University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 13, 2026 · JOURNAL ARTICLE

A case of Merkel cell carcinoma mimicking cellulitis during Janus kinase inhibitor therapy

Journal of Cutaneous Immunology and Allergy

A single case report with atypical clinical presentation and mechanistic speculation; describes one patient's course without a control group or comparative data, raising a signal rather than establishing causation.

PreliminaryDaiki Matsubara Takanobu Kan Takumi Sakamoto

Reported

Patient age74 years

Tofacitinib dose10 mg/day

Duration of JAK inhibitor exposure4 years prior to MCC presentation

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support